Authors: Stadler, WM Vogelzang, NJ Amato, R Sosman, J Taber, D Liebowitz, D Vokes, EE

Citation: Wm. Stadler et al., Flavopiridol, a novel cyclin-dependent kinase inhibitor, in metastatic renal cancer: A University of Chicago phase II consortium study, J CL ONCOL, 18(2), 2000, pp. 371-375

Authors: Giannola, DM Shlomchik, WD Jegathesan, M Liebowitz, D Abrams, CS Kadesch, T Dancis, A Emerson, SG

Citation: Dm. Giannola et al., Hematopoietic expression of HOXB4 is regulated in normal and leukemic stemcells through transcriptional activation of the HOXB4 promoter by upstreamstimulating factor (USF)-1 and USF-2, J EXP MED, 192(10), 2000, pp. 1479-1490

Authors: Chien, M Astumian, M Liebowitz, D Rinker-Schaeffer, C Stadler, WM

Citation: M. Chien et al., In vitro evaluation of flavopiridol, a novel cell cycle inhibitor, in bladder cancer, CANC CHEMOT, 44(1), 1999, pp. 81-87

Authors: Liebowitz, D Criminisi, A Zisserman, A

Citation: D. Liebowitz et al., Creating architectural models from images, COMPUT GR F, 18(3), 1999, pp. C39

Authors: Lokhorst, HM Liebowitz, D

Citation: Hm. Lokhorst et D. Liebowitz, Adoptive T-cell therapy, SEM HEMATOL, 36(1), 1999, pp. 26-29